NCT02022982
- Conditions
- KRAS Mutant Non-Small Cell Lung Cancer, Solid Tumors
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
KRAS Mutant Non-Small Cell Lung Cancer
Explore clinical trials studying KRAS Mutant Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies